Abacus Bioscience Inc
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease and oncology.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
208
organic / mo
Sign up free to see all 4 verified contacts at Abacus Bioscience Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- MM
Margaret McDaniel
Principal Scientist · Science
EmailPhone - EA
Edward A Clark
Founder and Chair, Scientific Advisor Board · Other
EmailPhone - LL
Leung Law
Chief Scientific Officer · Research & Development
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Abacus Bioscience Inc
3 distinct titles indexed · top 3 shown.
- 1chief scientific officer
- 1founder and chair, scientific advisor board
- 1principal scientist
Sign up to unlock all 4 contacts at Abacus Bioscience Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Abacus Bioscience Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.